GlassScriptPhysician profile
Robert J Hamilton
NPI 1386901080
$3,657.34
in general payments reported to CMS, 2019-2025
22 companies · $656 in 2025
The $656 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $408 · 2022: $752 · 2023: $607 · 2024: $1,234 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,910 · Travel and Lodging: $571 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,910.20 |
| Travel and Lodging | $570.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $1,267.04 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Intuitive Surgical, INC. | $616.51 | 2024 | |
| Astellas Pharma US INC | $439.84 | 2021-2025 | Veozah, Myrbetriq |
| Tolmar, INC. | $318.41 | 2023-2025 | Jatenzo, Eligard |
| Coloplast Corp | $226.23 | 2023-2025 | Speedicath |
| Janssen Biotech, INC. | $152.70 | 2021-2022 | |
| 180 Medical, INC. | $77.17 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $74.84 | 2022-2023 | Xiaflex, Aveed |
| Endo USA, INC. | $64.35 | 2024-2025 | Xiaflex, Aveed |
| Kowa Pharmaceuticals America, INC. | $62.78 | 2022-2023 | Seglentis |
| Hollister Incorporated | $58.35 | 2023-2024 | Vapro Pocket |
| Acerus Pharmaceuticals Corporation | $45.00 | 2022 | |
| Verity Pharmaceuticals INC. | $41.90 | 2025 | Trelstar |
| Abbvie INC. | $33.50 | 2022-2024 | |
| Urogen Pharma, INC. | $33.16 | 2023-2024 | Jelmyto |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $29.75 | 2024 | |
| Urovant Sciences INC | $28.15 | 2022 | |
| Progenics Pharmaceuticals, INC. | $23.79 | 2025 | |
| Halozyme INC | $16.40 | 2023 | |
| Photocure INC | $16.37 | 2024 | Cysview |
| Axonics, INC. | $15.66 | 2024 | Axonics |
| E.R. Squibb & Sons, L.L.C. | $15.44 | 2023 | Opdivo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.